Get the Stockscreener App
0.5972
2.76%
-0.017
After Hours:
.60
0.00285
+0.48%
Basel Medical Group Ltd stock is traded at $0.5972, with a volume of 10,110.
It is down -2.76% in the last 24 hours and down -3.69% over the past month.
Basel Medical Group Ltd provides general and subspecialized orthopedic, trauma and sports medicine services such as knee/hip replacements, sports medicine/surgery, spine surgery, foot/ankle surgery and minimally invasive orthopedic procedures, as well as neurosurgical treatments. The services provided by clinics include, but are not limited to, consultation, medical diagnosis and medical or surgical treatments for orthopedic, trauma, sports medicine, general practice, health screening, mental health, women's health and neurosurgical conditions and clinics are equipped with the facilities needed to perform a variety of procedures on site and minor surgical services. Key revenue is generated from Singapore.
See More
Previous Close:
$0.6141
Open:
$0.6066
24h Volume:
10,110
Relative Volume:
0.44
Market Cap:
$11.22M
Revenue:
$8.55M
Net Income/Loss:
$-8.03M
P/E Ratio:
-1.3962
EPS:
-0.4277
Net Cash Flow:
$-3.48M
1W Performance:
-9.00%
1M Performance:
-3.69%
6M Performance:
-49.82%
1Y Performance:
-49.39%
1-Day Range:
$0.5737
$0.6066
1-Week Range:
$0.5737
$0.6887
52-Week Range:
$0.4872
$9.40
Basel Medical Group Ltd Stock (BMGL) Company Profile
Name
Basel Medical Group Ltd
Sector
Industry
Phone
-
Address
-
Compare BMGL vs HCA, THC, DVA, FMS, EHC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BMGL
Basel Medical Group Ltd
|
0.5972 | 11.54M | 8.55M | -8.03M | -3.48M | -0.4277 |
HCA
Hca Healthcare Inc
|
394.07 | 87.09B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
173.78 | 15.33B | 21.46B | 2.65B | 3.35B | 19.23 |
DVA
Davita Inc
|
198.52 | 12.75B | 13.84B | 1.10B | 1.49B | 10.42 |
FMS
Fresenius Medical Care Ag Adr
|
21.64 | 12.09B | 22.18B | 1.36B | 2.00B | 1.9216 |
EHC
Encompass Health Corp
|
104.96 | 10.36B | 6.07B | 793.80M | 464.40M | 5.9914 |
Basel Medical Group Ltd Stock (BMGL) Latest News
BMGL Stock Price, Quote & Chart | BASEL MEDICAL GROUP LTD (NASDAQ:BMGL) - ChartMill
Basel Medical Group receives delinquency notification from Nasdaq - MSN
TradingKey - tradingkey.com
Number of shareholders of Basel Medical Group Ltd – NASDAQ:BMGL - TradingView
What Basel Medical (BMGL) is doing that separates it from the herd (-0.13%) 2026-05-08High Interest Stocks - Newser
Basel Medical Group receives S$375 million contract to supply healthcare products - MSN
Basel Medical Group Ltdordinary shares (Nasdaq:BMGL) Stock Quote - The Chronicle-Journal
BMGL Investors Have Opportunity to Join Basel Medical Group Ltd Fraud Investigation with the Schall Law Firm - GlobeNewswire
Evolent Health (EVH) Stock Chart | Q4 2025: Profit SurprisesWall Street Views - Cổng thông tin điện tử tỉnh Lào Cai
12 Health Care Stocks Moving In Wednesday's Pre-Market SessionAxe Compute (NASDAQ:AGPU), Alpha Compute - Benzinga
Director at Basel Medical (BMGL) files Form 3 ownership statement - Stock Titan
Psyence (PBMWW) Stock: Support and Resistance (Technical Strength) 2026-04-20Most Discussed Stocks - Cổng thông tin điện tử tỉnh Lào Cai
Basel Medical (BMGL) Stock: Why It Could Accumulate (Momentum Building) 2026-04-20Trending Entry Points - Xã Thanh Hà
Keng Leong Fung Net Worth (2026) - GuruFocus
Tony Chen Net Worth (2026) - GuruFocus
Would buying Basel Medical (BMGL) stock now make sense (-4.83%) 2026-04-18Crowd Trend Signals - Cổng thông tin điện tử tỉnh Lào Cai
Jianing Jn Lu Net Worth (2026) - GuruFocus
Boon Chye Tan Net Worth (2026) - GuruFocus
Chhoa Darren Yen Feng Net Worth (2026) - GuruFocus
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Basel Medical (BMGL) CFO files initial insider ownership Form 3 - Stock Titan
Rosen Law Firm Encourages Basel Medical Group Ltd. Investors to Inquire About Securities Class Action Investigation – BMGL - Bluefield Daily Telegraph
Basel Medical Group (BMGL) director Tony Chen files initial Form 3 - Stock Titan
[Form 3] Basel Medical Group Ltd Initial Statement of Beneficial Ownership - Stock Titan
Basel Medical (BMGL) CCO reports 10.2M shares held via Rainforest - Stock Titan
Basel Medical (BMGL) director details 10.2M indirect shares via funds - Stock Titan
Rosen Law Firm Encourages Basel Medical Group Ltd. Investors to I - The National Law Review
Bull Bear: Is MLNK currently under institutional pressure2026 Macro Impact & Real-Time Chart Breakout Alerts - baoquankhu1.vn
Smart Money: Is Basel Medical Group Ltd stock a top performer YTD2026 Pullbacks & Real-Time Stock Movement Alerts - baoquankhu1.vn
Can Basel Medical (BMGL) Stock Recover Now | Price at $0.61, Up 2.17%Pro Trader Recommendations - Newser
Is Targa Resources (TRGP) Stock in a Buying Zone | Price at $245.65, Up 0.52%Gamma Alerts - Xã Thanh Hà
Sera Prognostics (NASDAQ:SERA) and Basel Medical Group (NASDAQ:BMGL) Head to Head Survey - Defense World
BMGL Stock Analysis: Basel Medical Group Ltd down 3.09% at $0.59 performance review - Newser
Stock List: Research Stocks from Around the World - GuruFocus
BMGL Stock Analysis: Basel Medical Group Ltd Ordinary Shares flat at 0.59 today - Cổng thông tin điện tử tỉnh Lào Cai
BMGL Should I Buy - Intellectia AI
Basel Medical Group Reshapes Board with New Director Appointment - The Globe and Mail
Day Trade: Will BBB Foods Inc benefit from current market trendsBear Alert & Long-Term Growth Plans - baoquankhu1.vn
Bank Watch: How correlated is Basel Medical Group Ltd to the S P5002026 Key Lessons & Advanced Swing Trade Entry Plans - baoquankhu1.vn
Basel Medical Group appoints Darren Tan to board as Jianing Lu steps down - Investing.com
Basel Medical Group (NASDAQ: BMGL) reshapes board as Darren Tan replaces Jianing Lu - Stock Titan
Basel Medical Group Ltd Announces Board Changes - marketscreener.com
USA Stocks: Research Stocks from USA Stock Market - gurufocus.com
Basel Medical Regains Nasdaq Compliance After Amended 2025 Annual Filing - The Globe and Mail
Basel Medical Group regains Nasdaq compliance on filing rule - Investing.com
Compliance With Nasdaq Periodic Filing Requirement - Bitget
Basel Medical Group regains Nasdaq compliance on filing rule By Investing.com - Investing.com Australia
Basel Medical Group (NASDAQ: BMGL) regains full compliance with Nasdaq filing rule - Stock Titan
Nasdaq closes Basel Medical filing deficiency after 2025 20-F - Stock Titan
Basel Medical Group Ltd Stock (BMGL) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.74%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):